Cucurbitacin B inhibits 12-O-tetradecanoylphorbol 13-acetate-induced invasion and migration of human hepatoma cells through inactivating mitogen-activated protein kinase and PI3K/Akt signal transduction pathways

Hepatology Research

Volumn 42, Issue 4, 2012, Pages 401-411

  Zhou, Xueying ^a   Yang, Jiao ^a,c   Wang, Yanli ^a   Li, Wen ^a   Li Ling, Jesse ^d   Deng, Yihui ^b   Zhang, Meixia ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c DAQING OILFIELD CO LTD   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

BEL 7402; Cucurbitacin B; Hepatoma; HepG2; Invasion; Matrix metalloproteinase 9

Indexed keywords

ANTINEOPLASTIC AGENT; CUCURBITACIN B; GELATIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE B; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASSAY; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL NUCLEUS; CELL STRAIN; CELL STRAIN HEPG2; DRUG EFFECT; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEPATOMA CELL; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY;

EID: 84863337986     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00933.x     Document Type: Article

References (26)

1. Rahbari NN, Mehrabi A, Mollberg NM etal. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 2011; 253: 453-69.
2. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 2010; 7: 448-58.
3. Zhu AX. Systemic treatment of hepatocellular carcinoma: dawn of a new era? Ann Surg Oncol 2010; 17: 1247-56.
4. van Zijl F, Zulehner G, Petz M etal. Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol 2009; 5: 1169-79.
5. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-87.
6. Uchino K, Tateishi R, Shiina S etal. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer 2011; 117: 4475-83.
7. Ko BS, Chang TC, Hsu C etal. Overexpression of 14-3-3epsilon predicts tumour metastasis and poor survival in hepatocellular carcinoma. Histopathology 2011; 58: 705-11.
8. Zhang CH, Xu GL, Jia WD etal. Activation of STAT3 Signal Pathway Correlates with Twist and E-Cadherin Expression in Hepatocellular Carcinoma and Their Clinical Significance. J Surg Res 2011: 1-10. Epub ahead of print.
9. Shih YW, Lee YC, Wu PF etal. Plumbagin inhibits invasion and migration of liver cancer HepG2 cells by decreasing productions of matrix metalloproteinase-2 and urokinase- plasminogen activator. Hepatol Res 2009; 39: 998-1009.
10. Lee YC, Lin HH, Hsu CH etal. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway. Eur J Pharmacol 2010; 632: 23-32.
11. Lee KH, Yeh MH, Kao ST etal. The inhibitory effect of hesperidin on tumor cell invasiveness occurs via suppression of activator protein 1 and nuclear factor-kappa B in human hepatocellular carcinoma cells. Toxicol Lett 2010; 194: 42-9.
12. Yeh MH, Kao ST, Hung CM etal. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells. Toxicol Lett 2009; 184: 204-10.
13. Yu H, Pan C, Zhao S etal. Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Biomed Pharmacother 2008; 62: 366-72.
14. Chen PS, Shih YW, Huang HC etal. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PLoS ONE 2011; 6: e20164.
15. Verma RP, Hansch C. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg Med Chem 2007; 15: 2223-68.
16. Weng CJ, Chau CF, Hsieh YS etal. Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappa B and AP-1. Carcinogenesis 2008; 29: 147-56.
17. Lee DH, Thoennissen NH, Goff C etal. Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma. Cancer Lett 2011; 306: 161-70.
18. Zhang M, Sun C, Shan X etal. Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling. Pancreas 2010; 39: 923-9.
19. Chan KT, Li K, Liu SL etal. Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562. Cancer Lett 2010; 289: 46-52.
20. Zhang M, Zhang H, Sun C etal. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B. Cancer Chemother Pharmacol 2009; 63: 635-42.
21. Pan MH, Chiou YS, Chen WJ etal. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Carcinogenesis 2009; 30: 1234-42.
22. Liu F, Qi HL, Chen HL. Regulation of differentiation- and proliferation-inducers on Lewis antigens, alpha-fucosyltransferase and metastatic potential in hepatocarcinoma cells. Br J Cancer 2001; 84: 1556-63.
23. Masure S, Billiau A, Van Damme J etal. Human hepatoma cells produce an 85kDa gelatinase regulated by phorbol 12-myristate 13-acetate. Biochim Biophys Acta 1990; 1054: 317-25.
24. Genersch E, Hayess K, Neuenfeld Y etal. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci 2000; 113 (Pt 23): 4319-30.
25. Simon C, Goepfert H, Boyd D. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92, 000 type IV collagenase secretion and in vitro invasion. Cancer Res 1998; 58: 1135-9.
26. Shin M, Yan C, Boyd D. An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim Biophys Acta 2002; 1589: 311-16.